Skip to main content

Day: October 25, 2021

Employees Vote Against Proposed Bargaining Agreement at Lantic’s Montreal Refinery

MONTREAL, Oct. 25, 2021 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Corporation”) (TSX: RSI) announced today that employees of the main bargaining unit of the its Montreal refinery have voted against the memorandum of agreement reached by Lantic, the Corporation’s wholly owned subsidiary, and union leaders last week. The parties agreed to meet in upcoming days to resume discussions. The Montreal refinery employs approximately 200 unionized workers. The collective bargaining process between Lantic and its four Montreal unions began last winter in light of the expiry of a 5-year collective agreement at the end of May. About Rogers Sugar Inc. Rogers is a corporation established under the laws of Canada. The Corporation holds all of the common shares of Lantic and its administrative office is in Montréal, Québec. Lantic operates cane...

Continue reading

SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company

Completed Business Combination with Big Cypress Acquisition Corp. Common stock to commence trading on the Nasdaq Global Market October 25, 2021, under the ticker symbol “SABS” SIOUX FALLS, S.D., Oct. 25, 2021 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the completion of its business combination with Big Cypress Acquisition Corp. (Nasdaq: BCYP) (“Big Cypress”), a publicly-traded special purpose acquisition company (SPAC) focused on innovative biopharmaceutical firms. The common stock and warrants of the resulting combined company, SAB Biotherapeutics Inc. will commence trading on the Nasdaq Global Market...

Continue reading

NFI receives orders for 173 coaches and buses from New Jersey Transit

ST. CLOUD, Minn., Oct. 25, 2021 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that the New Jersey Transit Corporation (“NJ TRANSIT”) has exercised options for 118 D4500 clean diesel commuter coaches, in its final year of an existing six-year contract (originally announced in 2015) with NFI subsidiary Motor Coach Industries (“MCI”). The order was converted from NFI’s backlog. Earlier this year, NJ TRANSIT also exercised and received delivery of additional options for 30 MCI D4500 commuter coaches and 25 clean-diesel, sixty-foot New Flyer Xcelsior® heavy-duty transit buses (50 equivalent units or “EUs”). The orders propel NJ TRANSIT’s fleet revitalization plan, replacing older, end-of-life...

Continue reading

Colliers releases ambitious Enterprise ’25 growth strategy

Plan continues focus on delivering balanced and diversified growth TORONTO, Oct. 25, 2021 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) today released its next five-year Enterprise ’25 growth strategy, once again setting bold targets to continue its proven track record of success. The Company plans to more than double its profitability, ​with at least 65% of adjusted EBITDA coming from recurring revenue, by the end of 2025. “Colliers’ enduring strength comes from our enterprising culture, global platform, leading expertise and growth mindset. Our balanced and diversified business model allows us to provide expert advice to our clients, wherever they choose to do business,” said Jay S. Hennick, Global Chairman and CEO. “We will continue to grow from...

Continue reading

Karolinska Development’s portfolio company AnaCardio strengthens its organization to facilitate clinical trial of the drug candidate AC01 in heart failure

STOCKHOLM SWEDEN – October 25, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company AnaCardio has strengthened its organization in preparation for the initiation of a phase 1b/2a study of its drug candidate AC01 in patients with heart failure. The company’s goal is to develop an orally available drug that, unlike current therapies, can affect the underlying cause of the disease. More than 100 million people suffer from heart failure, a potentially fatal condition with a one-year mortality rate of between 10 and 35 percent. Anacardio has recently recruited Patrik Strömberg as its new CEO. He holds a PhD in biochemistry from Karolinska Institutet, an MBA from the Department of Business Administration at Stockholm University and has many years of experience in drug development and business...

Continue reading

Generator Sales Market worth USD 33.54 billion by 2030, registering a CAGR of 6.67% – Report by Market Research Future (MRFR)

New York, Oct. 25, 2021 (GLOBE NEWSWIRE) — Generator Sales Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Generator Sales Market Research Report, Type, Fuel, End-Use and Portability and Region – Forecast till 2030”, the market is projected to be worth USD 33.54 billion by 2030, registering a CAGR of 6.67% during the forecast period (2021 – 2030), The market was valued at USD 20.35 billion in 2021. List of the companies profiled in the global generator sales market research report are-ABB Group (Switzerland) Siemens (Germany) General Electric Company (U.S.) Crompton Greaves Ltd. (India) Toshiba Corporation (Japan) Hyundai Heavy Industries Co. Ltd. (South Korea) Mitsubishi Electric Corporation (Japan) Hyosung Corporation (South Korea) Bharat Heavy Electricals Limited...

Continue reading

HBT Financial, Inc. Announces Third Quarter 2021 Financial Results

Third Quarter HighlightsNet income of $13.7 million, or $0.50 per diluted share; return on average assets (ROAA) of 1.37%; return on average stockholders’ equity (ROAE) of 14.29%; and return on average tangible common equity (ROATCE)(1) of 15.32% Adjusted net income(1) of $14.5 million; or $0.53 per diluted share; adjusted ROAA(1) of 1.45%; adjusted ROAE(1) of 15.08%; and adjusted ROATCE(1) of 16.18%(1)         See “Reconciliation of Non-GAAP Financial Measures” below for reconciliation of non-GAAP financial measures to their most closely comparable GAAP financial measures. BLOOMINGTON, Ill., Oct. 25, 2021 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial” or “HBT”), the holding company for Heartland Bank and Trust Company and NXT Bank, today reported net income of $13.7 million,...

Continue reading

uniQure Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress

~ Completed 78-week follow-up for hemophilia B pivotal study, with top-line data expected by year-end 2021 ~ ~ Enrolled 14 patients to date in Phase 1/2 clinical trial of AMT-130 in Huntington’s Disease, with no significant safety concerns observed ~ ~ Preliminary data on first four patients in ongoing Phase I/II clinical trial of AMT-130 and initiation of European Phase Ib/II clinical trial expected by year-end 2021 ~ ~ Closed acquisition of Corlieve Therapeutics adding preclinical program in temporal lobe epilepsy to proprietary research pipeline ~ LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 25, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the third quarter of 2021...

Continue reading

Tier-1 Mobile Operator in Asia Expands 4G Network with Gilat’s Cellular Backhaul Solution

Gilat’s field-proven carrier-grade VSATs to provide satellite backhaul to hundreds of sites of the nationwide 4G network PETAH TIKVA, Israel, Oct. 25, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that a Tier-1 mobile operator in Asia expanded its 4G network with Gilat’s cellular backhaul solution. Gilat’s field-proven carrier-grade VSATs to provide satellite backhaul to hundreds of sites of the nationwide 4G network. The 4G network was extended to provide coverage to additional sites in small cities and rural areas. Gilat’s SkyEdge II-c resilient platform with the high-performance Capricorn VSATs provide the backhaul over satellite to enable high speed data and high-quality...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.